The largest database of trusted experimental protocols

Mouse metastatic mammary 4t1 tumor cell line

The mouse metastatic mammary 4T1 tumor cell line is a widely used model for studying breast cancer metastasis. This cell line is derived from a spontaneously occurring mammary tumor in a BALB/c mouse. It is highly aggressive and metastatic, making it a valuable tool for researchers investigating the mechanisms of cancer spread and potential treatment strategies.

Automatically generated - may contain errors

3 protocols using mouse metastatic mammary 4t1 tumor cell line

1

Metastatic Breast Cancer Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mouse metastatic mammary 4T1 tumor cell line (Cat# CRL-2539) and human MDA-MB-231 breast adenocarcinoma cell line (Cat# HTB-26) were purchased from the American Type Culture Collection (ATCC). The MDA-MB-231-Luc-D3H2LN Bioware (D3H2LN) cell line [49 (link)] was purchased from PerkinElmer (Cat# 119369). The mouse mammary tumor MMTV-Myc cell line has been previously reported [25 (link), 50 (link)]. Cell lines were authenticated by short tandem repeat (STR) profiling in accordance with the standard ASN-0002-2011 in April 2015 and March 2016 (DDC Medical). 4T1 cells were maintained in RPMI supplemented with 10% fetal bovine serum (FBS) and 1% Antibiotic-Antimycotic solution (Invitrogen). The MDA-MB-231 cell line was maintained in DMEM supplemented with 10% FBS, 1% GlutaMAX (Invitrogen), 10 mM HEPES, 1 mM sodium pyruvate, non-essential amino acids and 1% Antibiotic-Antimycotic solution. MMTV-Myc cells were cultured in DMEM/F12 medium supplemented with 5% FBS, 1% GlutaMAX, 10 mM HEPES, and 1% Antibiotic-Antimycotic solution.
+ Open protocol
+ Expand
2

Breast Cancer Cell Lines and Drug Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mouse metastatic mammary 4T1 tumor cell line (Cat# CRL-2539) and human MDA-MB-231 breast adenocarcinoma cell line (Cat# HTB-26) were purchased from the American Type Culture Collection (ATCC). The MDA-MB-231-Luc-D3H2LN Bioware (D3H2LN) cell line (16 (link)) was purchased from PerkinElmer (Cat# 119369). The mouse mammary tumor MMTV-Myc cell line has been previously reported (17 (link), 18 (link)). Cell lines were authenticated by short tandem repeat (STR) profiling in accordance with the standard ASN-0002-2011 in April 2015 (DDC Medical, Fairfield, OH). 4T1 cells were maintained in RPMI supplemented with 10% fetal bovine serum (FBS) and 1% Antibiotic-Antimycotic solution (Invitrogen). D3H2LN and MDA-MB-231 cell lines were maintained in DMEM supplemented with 10% FBS, 1% GlutaMAX (Invitrogen), 10mM HEPES, 1mM sodium pyruvate, non-essential amino acids and 1% Antibiotic-Antimycotic solution. MMTV-Myc cells were cultured in DMEM/F12 medium supplemented with 5% FBS, 1% GlutaMAX, 10mM HEPES, and 1% Antibiotic-Antimycotic solution. Ivermectin was purchased from Sigma. Selamectin was synthesized in-house.
+ Open protocol
+ Expand
3

Characterization of Metastatic Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mouse metastatic mammary 4T1 tumor cell line (Cat# CRL-2539) and human MDA-MB-231 breast adenocarcinoma cell line (Cat# HTB-26) were purchased from the American Type Culture Collection (ATCC). The mouse mammary tumor MMTV-Myc cell line has been previously reported [62 (link), 63 (link)]. Cell lines were authenticated by short tandem repeat (STR) profiling in accordance with the standard ASN-0002-2011 in April 2015 (DDC Medical). 4T1 cells were maintained in RPMI supplemented with 10% fetal bovine serum (FBS) and 1% Antibiotic-Antimycotic solution (Invitrogen). The MDA-MB-231 cell line was maintained in DMEM supplemented with 10% FBS, 1% GlutaMAX (Invitrogen), 10mM HEPES, 1mM sodium pyruvate, non-essential amino acids and 1% Antibiotic-Antimycotic solution. MMTV-Myc cells were cultured in DMEM/F12 medium supplemented with 5% FBS, 1% GlutaMAX, 10mM HEPES, and 1% Antibiotic-Antimycotic solution. Stable knockdown of PF1 in MDA-MB-231 was performed with pLKO-PF1 shRNA (clone# TRCN0000015704), which was a kind gift from the laboratory of Gregory David (NYU School of Medicine, NY, USA) [44 (link)]. A second pLKO-PF1 shRNA construct (clone# TRCN0000084422, Sigma Aldrich) was used for stable knockdown in mouse 4T1 cells. Stable transfections were performed with 1 μg of DNA using TurboFect (ThermoScientific) according to the manufacturer's recommendations.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!